A Method To Measure Pay-For-Delay Drugs' Financial Impact

Pay-for-delay agreements, in which a brand name pharmaceutical company agrees to pay a generic drug company to delay the release of the generic version of the brand name drug, have been...

Already a subscriber? Click here to view full article